Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-25-000033

Chief Legal Officer & Corp Sec sold 3,418 shares at $1.59 ($5,435)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meisner Derek M Chief Legal Officer & Corp Sec 2025-01-21 Sale 10b5-1 −3,418 $1.59 $5,435 161,127 D
Open-market sales · 3,418 sh · avg $1.59 · $5,435
Loading xslF345X05/wk-form4_1737670600.xml…